Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The pediatric advanced practice provider (APP) provides care for pediatric blood and marrow transplant patients in both inpatient and outpatient setting under the supervision of the attending physician. The APP is responsible for the primary care of the patient to include assessment, triage and management of the transplant patient as part of a collaborative transplant team. Responsibilities include obtain medical history, perform physical examinations, review and order diagnostic studies, radiographs and prescribe treatments. APPs provide follow-up care of bone marrow donors under the supervision of attending physician. PALS certification is required for this position within 3 months of hiring date.
Please include a cover letter when applying for this job that includes your specific interest in the Advanced Practice Provider position and working for Fred Hutch (either as an additional attachment on your profile or merged into the file that contains your resume.)
Hematopoietic Cell Transplant (HCT) and Immunotherapy (IMTX) Programs
The Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine are jointly recruiting a full-time faculty member at the Assistant Member/Assistant Professor or Associate Member/Associate Professor level without tenure due to funding (WOT), commensurate with experience, in the Clinical Research Division of the Fred Hutch and the Division of Medical Oncology, Department of Medicine at the UW. This position has an annual service period of 12 months [July 1-June 30]. The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
The primary appointment will be in the Clinical Research Division of Fred Hutch. The selected individual for the advertised position is expected to enhance our clinical care and clinical research programs in hematopoietic cell transplantation and immunotherapy. All clinical research interests will be considered however, there is a particular interest in applicants with demonstrated experience in the field of immunotherapy. Applicants with extensive research experience will also be considered. University of Washington faculty engage in teaching, research and service.
Anticipated start date January 2, 2019
Hematopoietic Cell Transplant Program
The Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Medical Oncology, are jointly recruiting a full-time faculty member at the Assistant Member/Assistant Professor or Associate Member/Associate Professor level without tenure due to funding (WOT), commensurate with experience, in the Clinical Research Division of the Fred Hutch and the Division of Medical Oncology, Department of Medicine at the UW. This position has an annual service period of 12 months [July 1-June 30]. The primary appointment will be in the Clinical Research Division of Fred Hutch. The selected individual for the advertised position is expected to enhance our clinical research and clinical care programs in hematopoietic cell transplantation and immunotherapy. The successful candidate will be a prominent thought leader in the field of Stem Cell Transplantation who is engaged in innovative laboratory-based research investigating the mechanisms and/or treatment of malignant relapse after transplantation, which may include leukemia intrinsic and/or immunological mechanisms of immune escape. Fred Hutch and University of Washington faculty engage in teaching, research and service.
The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
Anticipated start date would be June 1, 2020.
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Paulovich Lab at Fred Hutch is an interdisciplinary team whose mission is to develop and implement tools for protein quantification to enable precision medicine via patient selection and characterization of novel therapeutic targets. The lab has a major focus on mass spectrometry (MS)-based proteomics (both untargeted and multiple reaction monitoring), as well as integrating proteomic data with genomic and metabolomic data. Our group is highly collaborative, participating in national and international consortia in which teams of scientists, statisticians, and clinicians work together to solve clinical or biological problems to impact human health.
This is a terrific opportunity within the Paulovich lab for a data scientist to work closely with our interdisciplinary team of chemists, biologists, clinicians, and statisticians to leverage multi-omic datasets to understand and predict human cancer responses to therapies. We are looking for a highly motivated, interactive, Bioinformatics/ Computational Biologist to join our proteomics team to help drive translational projects forward towards clinical applications by performing analysis and interpretation of multidimensional “-omics” datasets (DNA, RNA, protein, metabolite, and clinical phenotype) from human tumors and preclinical models. The candidate will participate in the development of data pipelines, plan and conduct analyses, interpret results, design and implement data visualizations, and help prepare figures and text for funding proposals, reports, and publications. The ideal candidate should have the ability to work independently as one hub in an interdisciplinary team.
Required
Preferred
The Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Medical Oncology are jointly recruiting a full-time faculty member at the Research Associate/Acting Instructor level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.
The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
The selected individual for the advertised position is expected to participate in a year-long fellowship program with the goal of becoming an expert in blood and marrow transplantation (BMT) and immunotherapy (IMTX) services at Fred Hutch. The individual holding this position will rotate through outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up) and IMTX services, and initially function as a primary care provider with increasing levels of patient care responsibility over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available for the opportunity to participate in clinically focused research projects. University of Washington faculty engage in teaching, research and service.
Anticipated start date would be July 1, 2020.
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Data Coordinator (DC) is responsible for the documentation and monitoring of Phase 1-3 clinical trials, including the collection, coordination, processing and quality control of clinical trial data. The position will track clinical activity and subject visits, and abstract and report data. The DC will work on studies for at least two investigators, and regularly update those investigators on progress and activity. The DC will work closely with a Clinical Research Coordinator and will report directly to the Clinical Program Operations Director.
The Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Pediatrics, Division of Hematology Oncology are jointly recruiting a full-time faculty member at the Research Associate/Acting Instructor level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.
The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
The selected individual for the advertised position is expected to participate in a year-long fellowship program with the goal of becoming an expert in bone marrow transplantation and Immunotherapy. This position will rotate through outpatient Hematopoietic Cell Transplantation (HCT) services (autologous and allogeneic BMT, IMTX, Long Term Follow Up) and inpatient services initially as a primary care provider with increasing levels of independent patient care responsibility over the course of the year. Approximately 75% of the year will be devoted to clinical activities with the remaining time available for the opportunity to participate in clinically focused research projects, which will be determined based on identification of mentors and projects. University of Washington faculty engage in teaching, research and service.
Anticipated start date would be July 1, 2020.
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The post-doctoral research fellow will work on independent and collaborative projects in Dr. Chapuis laboratory developing adoptive T cell immunotherapy for viral driven malignancies within the Program in Immunology and Clinical Research Division at Fred Hutchinson Cancer Research Center. The successful applicant will employ strategies for cloning T cell receptors (TCRs) and genetic modification of human T cells with TCRs specific for antigens expressed by malignancies. In vitro studies using human T cells and in vivo murine models will be used to develop and test novel T cell therapies. The research fellow will perform correlative studies to evaluate the transfer, persistence and function of antigen-specific T cells in human clinical trials of adoptive T cell immunotherapy.
The Program in Immunology is a leader in the development and clinical application of adoptive immunotherapy using genetically modified T cells and is committed to the advancement of this approach. The post-doctoral research fellow may also participate in the laboratory evaluation of ongoing clinical trials involving engineering of peripheral blood stem cell grafts for improved allogeneic hematopoietic stem cell transplantation outcomes, and in the development of future immunotherapy strategies. This is a full-time position with a salary based on the NIH scale and excellent benefits.
To be successful in this position, the post-doctoral research fellow must be highly motivated and driven to establish a career as a future independent investigator, will need to be able to work independently and play well with others.
Cures Start Here. Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutch’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Careers Start Here.
A highly qualified and motivated post-doctoral research fellow is sought to join the laboratory of Dr. Sunil Hingorani (https://research.fhcrc.org/hingorani/en.html) at Fred Hutchinson Cancer Research Center in Seattle, WA.
Our laboratory investigates molecular and cellular mechanisms of pancreatic ductal adenocarcinoma (PDA) pathogenesis. The murine models of distinct genetic subtypes of pancreas cancer that we have developed form the basis of our integrated, systematic, and multidisciplinary research program. Our efforts are directed at identifying and overcoming stromal barriers to treatment (including elevated interstitial pressures, activated fibroblasts, and multiple mechanisms of immune suppression); identifying and disrupting molecular drivers of metastasis; and developing immune-based strategies. Our ultimate aim is to reduce our discoveries to practice in the clinic in order to radically transform the approach and prognosis for patients with this devastating disease.
Successful applicants will have:
Cures Start Here. Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutch’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Careers Start Here.
The Walter Laboratory in the Clinical Research Division is recruiting an outstanding postdoctoral research fellow to work as part of a team investigating new treatments for patients with acute myeloid leukemia (AML) primarily focused on improving existing, and developing novel, antibody-based immunotherapies, and rendering them safer for clinical application. Current projects include preclinical drug development/testing (in part with academic and industry partners), studies on mechanisms of action and resistance of antibody-based therapeutics and identification of strategies to overcome these limitations, and development of approaches to protect normal tissues from the toxicities of AML-targeted therapies (e.g. via use of genome editing). We anticipate this position will commence July/August 2020.
The newly hired fellow will work under the direction of the Principal Investigator and senior laboratory personnel and will be involved in the following techniques/duties:
Required qualifications:
To be successful in this position, the postdoctoral research fellow must be organized, clear and concise in their communication, enthusiastic, a team player, and have a desire to establish a career as a future independent investigator. Fellowship opportunities are available through several philanthropic and government organizations; fellow will have administrative support for the application process.
Applicants must include:
Cures Start Here. Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutch’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Careers Start Here.
A postdoctoral position is immediately available in the laboratory of Dr. Stanley Lee at Fred Hutchinson Cancer Research Center. The Lee lab has a longstanding interest in understanding how defects in RNA processing and chromatin regulation drive hematologic malignancies, and how to devise mechanism-based strategies to therapeutically target these pathways in cancer (PMIDs: 30107174, 27135740, 27603132, 31334570.) Fred Hutch also offers a great research environment including state-of-the-art Shared Resources and Core Facilities and a robust Postdoctoral Fellowship Program to provide advanced training for future scientific leaders.
The successful candidate will be responsible for project design, execution, management and data analysis relating to RNA processing/chromatin regulation in stem cell biology and blood cancers. Projects will use a variety of experimental and computational approaches including in vitro and in vivo models (genetically engineered murine models (GEMMs) and patient derived xenografts (PDXs)), transcriptomic, epigenomic and proteomic analyses, molecular assays and functional genomics approaches. The fellow will work directly with the PI, members of the laboratory and external collaborators. The fellow will be expected to acquire a thorough understanding of the scientific literature, present in internal and external meetings, and draft manuscripts for peer-reviewed publications.
Please apply online and include a CV, cover letter with a brief description of past research experience and future goals, and contact information for three references.
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
Reporting to the Senior Operations Director, the Research Administration Manager II, an essential part of the Stem Cell and Gene Therapy Program and of the Clinical Research Division (CRD) Administrative team, will work under the direction of the Program Head. Investigators within the Stem Cell & Gene Therapy Program conduct research using large and small vertebrate animals and infectious agents, as well as clinical trials requiring GMP, FDA and IND compliance. Responsibilities of the Research Administration Manager II will include management and oversight for program finance and administration, grants and contracts, and regulatory compliance, as well as compliance with Center policies and procedures. The Manager also plays an important role in staff recruitment, training and performance management.
Required:
Preferred:
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Research Administrator III-IV proactively provides compliant and effective funding, budget and regulatory administration and general administrative support for one or several Principal Investigators and their labs/departments
The Research Administrator III-IV collaborates with Principal Investigator(s) and interfaces with other departments as needed to provide research administration and to contribute to strategic planning as it relates to their work portfolio. The Research Administrator III-IV may work in an autonomous manner to complete non-scientific grant content, tasks, and to advise PI(s) on relevant matters.
Budget/Fiscal Support
Funding Source Administration
Regulatory Support
Administrative Support
Clinical Trials Addendum
Required:
Preferred:
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Program in Immunology in the Clinical Research Division is looking for a highly motivated individual to support the development of immunotherapy for cancer. This individual will have the opportunity to work with a variety of cutting-edge cellular and molecular research techniques. This person will be responsible for maintaining meticulous records and organizing and reporting on experimental results. Duties will include:
Please note that part of the job responsibilities include collecting and/or processing samples from patients enrolled on clinical trials, which may require working outside of typical work hours and infrequently on weekends.
Minimum qualifications:
Research Techn I minimum qualifications- BA/BS in a scientific field required. Must have scientific knowledge in the area of study and basic laboratory skills. Independent research experience in addition to school lab experience is usually necessary.
Research Techn II minimum qualifications- Intermediate level position requiring 2 years previous experience working in a laboratory and BA/BS. Independent research experience outside of laboratory course work is usually necessary.
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
A Clinical Research Division laboratory that studies the biology of blood and marrow stem cells and develops novel stem cell gene therapies as well as genome editing technologies is recruiting a research technician I/II with a focus on bench research. This position will support research activities that include but are not limited to:
Minimum qualifications:
Research Techn I minimum qualifications- BA/BS in a scientific field required. Must have scientific knowledge in the area of study and basic laboratory skills. Independent research experience in addition to school lab experience is usually necessary.
Research Techn II minimum qualifications- Intermediate level position requiring 2 years previous experience working in a laboratory and BA/BS. Independent research experience outside of laboratory course work is usually necessary.
Preferred qualifications:
Your search for "" did not match any of our available careers. Please try another search term or combination of terms and filters.